Asian Logistics, Maritime and Aviation Conference Goes Online

HONG KONG, Oct 28, 2020 - (ACN Newswire) - In light of the global pandemic, the 10th Asian Logistics, Maritime and Aviation Conference (ALMAC), an annual signature event for the industries jointly organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), is being held online for the first time.


The 10th Asian Logistics, Maritime and Aviation Conference (ALMAC) will be held online on 17 and 18 November. Themed "Capturing Opportunities Amidst Volatility", more than 40 luminaries from the logistics, maritime and aviation sectors will share their insights on industry prospects and business opportunities.


Running on 17 and 18 November under the theme "Capturing Opportunities Amidst Volatility", ALMAC Online will focus on three key areas - rebuilding supply chain resilience under the new normal, Asia's evolving role in global supply chains, and the trendsetting technologies and innovations for reinvigorating logistics operations and management - to help industries navigate through a challenging business environment. More than 40 leaders from the logistics, maritime and aviation sectors will share their insights at the event, which is expected to attract around 2,000 industry elites from 25 countries and regions.

"The COVID-19 pandemic is creating significant obstacles to the global business environment, making this an unsettling year for the logistics, maritime and aviation industries. For the 10th iteration of ALMAC, we have created a brand-new online platform - the first time the HKTDC has ever staged its flagship conference online, providing a new experience unimpeded by geographical boundaries," said HKTDC Deputy Executive Director Patrick Lau.

"Industry representatives, professionals and stakeholders from across the globe will be able to participate and interact during the online conference. Industry leaders and experts will share their valuable experiences and strategies on supply chain resilience in the new normal and offer forecasts for global economic development in the post-pandemic world."

Dr Lau added that various new functions will be launched on the ALMAC Online platform, including business matching empowered by artificial intelligence (AI) and virtual meetings to bring together experts, shippers and participants to facilitate international exchanges and connections at any time.

World-renowned speakers examine the new normal

More than 40 industry experts will speak at 20 seminar sessions over the two days of ALMAC Online. On day one of the conference (17 November), the first Power Dialogue session will look at "Prospects for Asian Connectivity Under the New Normal". The pandemic has brought disruptions to the global supply chain, the likes of which have never been experienced before. To rebuild resilience and manage future risk better, many businesses are now looking to diversify their sourcing and production lines in Asia. And, as various Asian countries and territories actively promote trade agreements and regional development strategies, further integration and stronger connections can be expected within the Asian supply chain. At this first Power Dialogue session, Kelvin Leung, CEO, Asia Pacific, DHL Global Forwarding, and Grom Alexey Nikolaevich, CEO, Chairman of the Board, United Transport and Logistics Company - Eurasian Rail Alliance (UTLC ERA), will talk about the logistics industry's development and Asia's evolving role in the global supply chain.

The impact of the pandemic on the logistics industry has been widespread, with global air freight and ocean freight shrinking substantially amid land border closures. In the keynote session on day two of the conference (18 November), titled "World Trade Outlook after the Pandemic Outbreak and in an Uncertain Trade Landscape", Yonov Frederick Agah, Deputy Director-General of the World Trade Organization, will share his view on the outlook for global trade in the coming years and examine the role of authorities in the face of new trade policy barriers and regulations.

The plenary session, "Leading Through the New Paradigm of Global Logistics Risks under an Uncertain Trading Environment and Cyber Disruptions", will discuss how geopolitical tensions and trade protectionism challenge the process of globalisation. Heavyweight speakers - including Jan Hoffmann, Chief, Trade Logistics Branch, United Nations Conference on Trade and Development; Kenny Ye, COO, Orient Overseas Container Line; and Mathieu Renard Biron, Managing Director, Global Freight Forwarding, Kerry Logistics - will exchange their insights and strategies for ensuring more resilient sourcing, production operations and networks in order to minimise global logistics risks.

Exploring industry issues from different perspectives

Various forums will cover a range of topical issues relating to the air freight and maritime sectors as well as supply chain management and logistics. Topics to be covered include the digital transformation of air freight, green shipping, social commerce, cross-border e-commerce and logistics technology, providing participants with a more complete picture of the latest market intelligence and business opportunities.

This year's Air Freight Forum will explore several salient topics including the outlook for global air cargo and demand expectations, operational agility from the perspective of airlines and freight forwarders, vaccine transport by air, cross-border e-commerce, and collaboration and digitalisation in the air freight industry. COVID-19 is being seen by many as a catalyst for change, and the maritime industry is no exception. The Maritime Forum will focus on digital transformation and green shipping, with leaders from international institutions, analysts and maritime industry technology experts coming together to provide intelligence on the roadmap for recovery and the outlook for the industry, evaluating how companies can adapt to the new normal to enhance their long-term operational efficiency.

The pandemic has also brought changes to the e-commerce business model, which will be analysed in the two Supply Chain Management Forums. Discussions will include logistics automation and robotics, e-commerce and risk management in logistics, and enhancing supply chain efficiency through innovation and technology.

Brand-new online sessions address industry issues

The MarketTalks session at ALMAC Online will provide the latest market insights and opportunity analysis, while the InnoTalks session will feature innovative solutions to help conference participants keep abreast of the technological developments in the logistics industry and generate new impetus in their business. The ALMAC Online platform also provides several interactive occasions to connect different industry players. Leading professionals and associations will provide complimentary advisory services at the Meet the Experts sessions, covering areas such as the regional supply chain, risk management and changing trade flows. ALMAC Online will also provide online networking and an AI-driven business matching service, creating connections between potential business partners.

The seminars and forums will bring together a range of noted speakers, including (in alphabetical order according to family name):

- Yonov Frederick Agah, Deputy Director-General, World Trade Organization
- Ben Au, General Manager, Empower SCM Ltd.
- Mathieu Biron, Managing Director, Global Freight Forwarding, Kerry Logistics
- Christopher Chan, Partner and Hong Kong Head of Shipping, Offshore and Logistics, Holman Fenwick Willan LLP
- Hing Chao, Executive Chairman, Wah Kwong Maritime Transport Holdings
- Vincent Clerc, CEO Ocean & Logistics, Maersk A/S
- Jan Hoffmann, Chief, Trade Logistics Branch, United Nations Conference on Trade and Development (UNCTAD)
- Kelvin Leung, CEO, Asia Pacific, DHL Global Forwarding
- James Li, Head of Operations, Shopee Cross-Border
- Kitack Lim, Secretary-General, International Maritime Organization
- Tom Lin, Hong Kong/Taiwan Supply Chain Director, Procter & Gamble Hong Kong Ltd
- Grom Alexey Nikolaevich, CEO, Chairman of the Board, United Transport and Logistics Company - Eurasian Rail Alliance (UTLC ERA)
- Jeremy Nixon, Chief Executive Officer, Ocean Network Express
- Fraser Robinson, CEO and Co-Founder, Beacon
- Brian Reed, Vice President, Supply Chain Optimization, GEODIS
- Kenny Ye, COO, Orient Overseas Container Line; CEO, Orient Overseas Container Line Logistics

Members of the media wishing to interview speakers can email interview requests to clayton.y.lauw@hktdc.org or christine.kam@hktdc.org by 10 November. For the latest programme and speaker list, please visit: https://www.almac.hk/main/en/.

Photo Download: https://bit.ly/34zl5da

About HKTDC

The Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via trade publications, research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on Twitter @hktdc and LinkedIn
Contact:
Christine Kam, Tel: +852 2584 4514, Email: christine.kam@hktdc.org Clayton Lauw, Tel: +852 2584 4116, Email: clayton.y.lauw@hktdc.org


Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

source http://www.acnnewswire.com/press-release/english/62325/

マツダ、「サステナビリティレポート2020」および「アニュアルレポート2020」を発行

HIROSHIMA, Japan, Oct 28, 2020 - (JCN Newswire) - マツダ株式会社(以下、マツダ)は、CSR(企業の社会的責任)の取り組みをまとめた「マツダサステナビリティレポート2020」*1と、経営・財務情報をまとめた「アニュアルレポート2020」*2を発行し、公式ウェブサイトで公表しました。

「マツダサステナビリティレポート2020」でご紹介する主な内容

トップメッセージ:
- 中期経営計画で定めた3つの重点領域への取り組み
- コロナ禍の経験をてこにしたビジネス構造の変革とステークホルダーへ向けた取り組み
- 事業活動を通じた社会課題解決への取り組みとSDGs*3達成への貢献

特集:
- 技術開発長期ビジョン「サステイナブル“Zoom-Zoom”宣言2030」の実現に向けた取り組みや、マツダ初の量産電気自動車「MAZDA MX-30」の開発に込めた想い
- 創立100周年を迎え、これまでマツダを支えてくださった皆さまへ感謝の気持ちをお伝えする取り組み

その他、マツダのCSRにおける6つの領域、「お客さま満足」「品質」「安全」「環境」「人間尊重」「社会貢献」での取り組み

「アニュアルレポート2020」でご紹介する主な内容

社長メッセージ:
- 中期経営計画の発表や新世代商品の導入など、2020年3月期の取り組み
- コロナ禍における取り組みや、中期経営計画見直しの方向性

企業価値向上に向けた取り組み:
- 創立100周年を迎えたマツダの飽くなき挑戦の歴史や歩み
- 中期経営計画の主要施策や財務指標
- 「サステイナブル“Zoom-Zoom”宣言2030」の実現に向けた取り組み、新世代商品

持続的成長を支える取り組み:
- マツダのCSR、コーポレートガバナンスや内部統制など経営管理体制

事業概況
- 日本・北米・欧州・中国・その他市場における販売実績や施策

マツダは次の100年に向け、人を第一に考えた「人と共に創る独自性」を大切にし、関係するすべての皆さまとの協業や共創を強化しながら、お客さまに愛着を持っていただける商品・技術・顧客体験の創造に、挑戦し続けてまいります。

本リリースの詳細は下記をご参照ください。
https://newsroom.mazda.com/ja/publicity/release/2020/202010/201027a.html

概要:マツダ株式会社

詳細は www.mazda.co.jp をご覧ください。


Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

NEC:ビジネスマッチングサービス「Biz-Create」における三重銀行、第三銀行との連携開始について

TOKYO, Oct 28, 2020 - (JCN Newswire) - 株式会社三井住友銀行(頭取CEO:髙島 誠、以下「三井住友銀行」)と、日本電気株式会社 (代表取締役 執行役員社長 兼CEO:新野 隆、以下「NEC」)が共同で運営を行うデジタル技術を活用したビジネスマッチングサービス「Biz-Create」において、株式会社三重銀行(取締役頭取:渡辺 三憲、以下「三重銀行」)と株式会社第三銀行(取締役頭取:岩間 弘、以下「第三銀行」)が参画することになりました。地方銀行初の参加となり、今後、地域や金融機関の枠を超えたネットワーキングを充実させてまいります。(Biz-Createサイト URL: https://biz-create-service.jp/#/SSTP0101)

1.「Biz-Create」の現状
現在、三井住友銀行及びNECで運営を行っております「Biz-Create」は、お客様同士のオンライン上での自由なコミュニケーションとビジネスマッチングを支援するSaaS型のサービスです。2019年5月のリリース後、2020年9月末時点で5,000社を超える企業にご利用いただき、お客さま同士による商談も月間で約800件行われており、本サービスのさらなる利便性向上と活性化に取り組んでいます。

2.本連携の経緯と今後の展望
今般、地域・金融機関の垣根を超えたビジネスマッチングを実現すべく、三重銀行・第三銀行との連携を開始します。これにより、「Biz-Create」というデジタル空間で、三井住友銀行・三重銀行・第三銀行のお客さまは、三行の取引先企業と相互につながることが可能になります。サービスが三行の顧客基盤へと拡がることで、マッチングの機会の拡大と質の向上につながります。また、NECのAI等のデジタル技術を活用することで、ビジネスマッチングの更なる精度向上やマッチングニーズの喚起等、本サービスの様々な付加価値向上を図ります。

今後、「Biz-Create」はより広がりのあるビジネスマッチングサービスの高付加価値デジタルプラットフォームとして、連携する金融機関等を拡大し、より多くのビジネス機会を創出していくことでお客さまの事業の発展、企業価値向上をサポートしてまいります。

3.システムリリース予定日
2020年11月12日(木)

本リリースの詳細は下記をご参照ください。
https://jpn.nec.com/press/202010/20201028_03.html

概要:日本電気株式会社(NEC)

詳細は www.nec.co.jp をご覧ください。


Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

コニカミノルタ、KDDI、NEC、au 5Gとローカル5Gを活用した「ハイブリッドの5Gオープンラボ」を開設

TOKYO, Oct 28, 2020 - (JCN Newswire) - コニカミノルタ株式会社 (本社:東京都千代田区、社長:山名 昌衛、以下コニカミノルタ)、KDDI株式会社 (本社:東京都千代田区、代表取締役社長:髙橋 誠、以下 KDDI)、日本電気株式会社(本社:東京都港区、代表取締役 執行役員社長 兼 CEO:新野 隆、以下NEC)の3社は、大阪府高槻市のコニカミノルタ「Innovation Garden OSAKA Center」内にau 5G基地局を設置すると同時に、ローカル5Gの免許取得を行い、5G技術を活用した新規ビジネス共創を目的とした「ハイブリッドの5Gオープンラボ」(以下 本オープンラボ)を2020年11月6日から開設します。

本オープンラボでは、日本でも稀なキャリア5Gとローカル5Gのハイブリッド開発環境を備えています。パートナーとの共創を一層深めながら、新たな製品やサービスを生み出し、社会価値を創造していきます。一般的なオフィス環境や工場などの製造現場、屋内外の連携などを想定した5G活用の実証実験を行うとともに、ローカル5Gの優位性の実証など、広く知恵と技術を集めて実用化に向けた共同実験の場として、今後さまざまな業界のパートナー企業や大学など研究機関にも提供していきます。

コニカミノルタは、当社独自の画像IoT/AI技術を通じて非接触、リモート、リアルタイムな対応が可能となるソリューションを創出することで、ニューノーマル(新常態)下に世界で働くプロフェッショナルや社会の皆さまへ安心安全な環境をお届けし、人間社会の進化に貢献します。

本リリースの詳細は下記をご参照ください。
https://jpn.nec.com/press/202010/20201028_02.html

概要:日本電気株式会社(NEC)

詳細は www.nec.co.jp をご覧ください。


Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

「Moonstakeウォレット乗り換えキャンペーン」開始のお知らせ、推薦で1,000円分のETHをプレゼント

SINGAPORE, Oct 28, 2020 - (JCN Newswire) - Moonstake(ムーンステーク)では、2020年10月26日から11月6日まで、「ウォレット乗り換えキャンペーン」を開催いたします。対象期間内に、新規でMoonstakeのウォレットを使い始めた皆さんに、抽選で50名に1,000円分のETHをプレゼントいたします。








Moonstakeは、創業以来、革新的なステーキングプロトコルを自ら開発することにより、アジア地域や世界規模で高まる需要に応えることを目指してきました。Moonstake のプロダクトは、ステーキング機能を備えているワンストップソリューションであり、ウェブウォレットとモバイルウォレット(iOS / Android)を介して、ユーザーが暗号資産の使用を円滑化し、暗号資産の可能性を 大化するためのゲートウェイになっています。現在、ADAに加え、Moonstakeのステーキングプールは、Cosmos、IRISnet、Ontology、Harmony、QTUM、Tezosのステーキングに対応しており、ユーザーに様々な選択肢を提供することで、暗号資産の利用と可能性を最大化するためのオールインワンゲートウェイを提供します。

多くのウォレットにおいてステーキング対応が可能な暗号資産が限定される中、Moonstakeのユーザーは、ステーキング可能な暗号資産の数を着実に増やし、アセットの管理、ステーキング、ステーキング報酬の受け取りなどのサービスを利用する際にウォレットを切り替えることなくワンストップでステーキングにアクセスすることができます。取引所などの第三者に預ける必要もなく、セキュリティも非常に高いです。

キャンペーン参加の2ステップ
Step1:Moonstakeウォレットにアカウントを開設
Step2:TwitterもしくはLINE@、メールから応募

デスクトップ版ウォレットのアカウント開設はこちら
https://wallet.moonstake.io/sign-up
モバイル・アプリケーション版のダウンロードはこちら
- iOS:https://apps.apple.com/us/app/moonstake-wallet/id1502532651
- Android:https://play.google.com/store/apps/details?id=io.moonstake.wallet

TwitterID:@moonstake
LINE@:https://lin.ee/O3v2unTG
メールアドレス:contact@moonstake.io

当選者には、応募いただいた手段で当選のご連絡をさせていただきます。その際に、ETH受け取り用のアドレスを確認させていただきます。

今後、DeFiに繋がる 先端ウォレットに乗り換えるのに、いまが絶好のタイミング! ぜひ、この機会に、Moonstakeウォレットを使い、キャンペーンに参加してください!

Moonstake(ムーンステーク)について

Moonstakeは、アジア地域や世界規模で高まる需要に応えるため、ステーキングプール・プロトコル開発のために設立されました。Moonstakeはステーキングプールのプロトコルを開発し、パートナーや会社を通してサービスを提供していきます。Moonstakeは暗号資産保有者にとって活発的な環境を提供するアジアにおいて最大ステーキングプールネットワークになることを目標としています。アジアを率いるエコシステムを構築していくためにEmurgo、Ontology、NEO、PundiX、Wanchain、Qurasらと、次々とメジャープロジェクトとのパートナーシップを拡大しています。さらに、日本最大のブロックチェーンハブのBinarystar、シンガポールCatalist上場企業のOIO Holdings Limited (SGX: OIO)、と提携しています。アドバイザーには、世界的なプロジェクトのLISKや、プロジェクトの著名プレイヤーを迎えています。 https://www.moonstake.io/


Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

Wintermar Offshore (WINS:JK) Reports 9M2020 Results

JAKARTA, Oct 28, 2020 - (ACN Newswire) - Wintermar Offshore Marine (WINS:JK) has announced results for 9M2020. Wintermar's Owned Vessel revenue for 9M2020 was 17% lower YOY at US$24.6 million and there was a slight improvement on a quarterly basis in 3Q2020 compared to 2Q2020.

--Owned Vessel Division

For the 9M2020 period, Owned Vessel Division recorded a gross loss of US$2.8 million, largely due to cancellations and postponement of contracts caused by the pandemic. Cost efficiency measures and a streamlining of the fleet undertaken since last year led to a 14% YOY decline in Owned Vessel direct expenses, which helped mitigate some of the losses.

On a quarterly basis, revenue for 3Q2020 was slightly improved as compared to 2Q2020 while direct expenses fell.

Measures taken to improve cost efficiency resulted in a 14% reduction in direct expenses for Owned Vessels. Fuel costs dropped sharply by 71% YOY while depreciation fell by 14% YOY due to the sale of 4 vessels in the period 1 January 2020 until 30 September 2020. However, due to the cost of extra precautions taken to ensure the health and safety of crew and clients crewing costs were only 3% lower YOY for 9M2020.

--Chartering and Other Services

Chartering was also negatively affected, contributing US$0.4 million to gross profit as compared to US$1 million in 9M2019. Other Services experienced a similar decline and contributed US$0.3 million to gross profit for 9M2020.

--Indirect Expenses and Operating Loss

Overall, indirect expenses were 15% lower YOY, totaling US$4.5 million for 9M2020. The biggest contributor to these savings was a 15% YOY decline in staff salaries. This was due to lower headcount as well as a voluntary salary reduction supported by all levels of management and staff to mitigate the impact of the pandemic. Marketing and travelling expenses fell YOY by 74% and 43% respectively while lower depreciation also contributed to the cost reduction for 9M2020 compared to 9M2019.

The Operating Loss was 17% YOY higher at US$6.5 million for 9M2020.

--Other Income, Expenses and Net Attributable profit

Interest expenses fell by 27% YOY to US$2.5 million, largely due to lower debt as the Company paid off US$5.7 million of bank loans over the past 9 months. Vessel sale proceeds of US$4,9 million added US$1.2 million to other income, while share of associate companies' losses widened to US$0.4 million from US$0.02 million.

For the nine months ending 30 September 2020, the net loss attributable to shareholders totalled US$7.4 million compared to US$5.7 million in 9M2019.

EBITDA for 9M2020 was US$9 million, compared to US$12.5 million booked in 9M2019.

--Oil & Gas Industry

Activity was slow during 3Q2020, as the world continued to grapple with measures to control the COVID-19 pandemic. In South East Asia, charter rates have been stagnant and are unlikely to drop much further as they are barely covering cash costs. However, leading indicators for oil and gas are turning more positive.

In its October report, the International Energy Agency (IEA) projected that world demand for oil would return to 96.1 million bpd by Q42020 compared to an average of 100.1 million bpd for 2019. This represents a sharp recovery from 2Q2020 where global oil demand fell to the lowest point at 83 million bpd. On the supply side, oil and gas production has been hit hard as many Exploration and Production companies have cut back on investments due to financial pressures. OPEC+ has shown high compliance in maintaining lower production. If IEA projections are achieved, excess oil inventories may be drawn down by end of 2020, which is potentially good news for oil price stability and strength in 2021.

A recent study by Rystad Energy has concluded that deepwater drilling costs have fallen to US$50/barrel, lower than US shale production costs. Should oil prices recover, there are several potential offshore projects in SE Asia which could provide increased gas supply.

SKK MIGAS, Indonesia's regulator for the upstream oil and gas sector, has just reiterated in October 2020 their plans to boost oil and gas production to achieve their target of 1 million bpd by 2030 from 746,000 bpd in 2020. Since Indonesia has several discovered but undeveloped fields, this would actually be an achievable goal if the government is able to deliver on their plans for enhanced oil recovery and exploration.

--Strategy and Outlook

As countries have started to ease their COVID-19 restrictions on travel and business activities, there has been a gradual but steady recovery in oil and gas demand. China, which was early to emerge from lockdown, has shown a sharp recovery in economic growth.

The economic slump and spike in unemployment worldwide is being addressed through stimulus packages proposed by governments around the world. The threat of a resurgence of the virus seems to be handled with more localized lockdown measures to limit the harsh economic effects of COVID-19 "lockdown" restrictions. All this points to a gradual recovery of demand for oil in the coming year.

Although 2020 results will continue to be plagued by the pandemic's effect on reducing oil demand, there has started to be more tendering activity in 4Q2020 which is indicative of better times in 2021.

Rystad Energy research is projecting growth in South East Asian gas production. Wintermar has been building up a presence in Malaysia, Brunei and Myanmar for the past few years, as we position the Company to be a major player in Asia.

Contracts on hand as at end September 2020 amount to US$70 million.
Contact:
Ms. Pek Swan Layanto, CFA Investor Relations PT Wintermar Offshore Marine Tbk Tel: +62-21 530 5201 Ext 401 Email: investor_relations@wintermar.com


Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

source http://www.acnnewswire.com/press-release/english/62321/

LEXUS、「LC」特別仕様車"AVIATION"の限定発売を発表、「RC」に特別仕様車"Emotional Ash"を設定

TOKYO, Oct 28, 2020 - (JCN Newswire) - LEXUSは、「LC」に特別仕様車"AVIATION"を設定し、全国のレクサス店を通じて2021年1月6日に70台限定で発売します。2020年内に「LC」特別仕様車"AVIATION"をご成約いただいたお客様は、室屋 義秀選手との特別なイベントにご招待いたします。さらに、「RC」に特別仕様車"Emotional Ash"を設定し、全国のレクサス店を通じて2020年10月28日に発売しました。

LC
LCの特別仕様車"AVIATION"は鋭く優雅に大空を舞う、鳥や航空機の姿からインスピレーションを受けて、空力技術に着目し、より操縦性の高い走りを目指しました。鳥を語源に持ち、飛行を意味するAVIATIONをテーマとし、新開発の技術を応用し卓越した空力性能を実現する装備と、空から見た大地の雄大さを表現した特別な内装を採用しました。

LCの特別仕様車"AVIATION"はLC500h/LC500をベースに、空気の流れを運動性能および乗り心地に利用する「空力操安技術」を用い、LCの力強いエクステリアと空力の機能性との両立にこだわった、特別仕様車専用のCFRP*1リヤウィングを採用。さらに、ステアリングやシフトノブなどにアルカンターラ(R)を採用し、極細繊維の繊細さから生み出される滑らかな質感を手のひらに伝えるなど、クルマを操る喜びを追求しました。

特別仕様車専用のCFRP*1リヤウィングは、室屋 義秀選手との技術交流から得られた知見を活かして、航空機に用いられている空力技術を応用しました。一般的なリヤウィングはダウンフォースを生み優れた走行安定性を確保するのに対して、専用ウィングは、車両側面の空気の流れを制御することで、素早いヨーレスポンスと滑らかな車両姿勢の変化を実現します。具体的には、航空機の主翼の端部にあるウィングレットから着想を得て、空力性能を追求した結果、ウィング端部を車両の側面まで下ろした独自の形状を採用。ウィングの端部から、車体の後方側面に沿った縦渦を生成し、空気抵抗や車体揺れの原因となる気流の巻き込みを抑制します。これにより、直進安定性、ヨーレスポンス、ステアリングの手応えといった車両の運動性能と乗り心地を速度域問わず高いレベルで両立し、優れた操縦性/走行安定性を実現しています。また、理想的な形状と軽量化・高剛性化を実現するためにCFRP*1を採用。LFA工房の職人によって一枚ずつ仕上げられ、LCのエクステリアデザインとの調和や美しいカーボンの織り目も特長としています。

さらに高い剛性と空力性能を兼ね備えたスプリット5本スポークのアルミホイールを特別装備したほか、トルセン(R)LSD*2など、LCの走りの特徴である鋭く、優雅な走りをより一層磨き上げました。

エクステリアは、フロントグリルや前後のランプのガーニッシュなどをブラック塗装とし、鋭く精悍な印象に仕上げました。また、外板色は、ホワイトノーヴァガラスフレーク、ソニックシルバー、ブラックの3色を設定。

内装色は、特別仕様車専用のAVIATION Blackを採用。サドルタンとのカラーコーディネートにより、空から見た大地の雄大さを表現しました。また、ステアリング、シフトノブのほか、センターコンソールやドアトリムの表皮にアルカンターラ(R)*3を採用し、手や体が触れる部分をしっとりとした触感で統一し、操る感覚をより一層研ぎ澄ませます。さらに、クッション表皮の縫い位置を深くしたフロントシートの柔らかな座り心地とあわせ、ドライバーを心地良く包み込みます。

エアロバティック・パイロット 室屋 義秀選手 プロフィール
3次元モータースポーツ・シリーズ「レッドブル・エアレース・ワールドチャンピオンシップ」に初のアジア人パイロットとして2009年から参戦。2016年、千葉大会で初優勝。2017年シリーズでは全8戦中4大会を制し、アジア人初の年間総合優勝を果たしました。国内ではエアロバティックス(曲技飛行)の啓蒙の一環として、全国各地でエアショーを実施。福島県とともに子ども向けの航空教室を開催するなど、スカイスポーツ振興のために地上と大空を結ぶ架け橋となるべく活動中。また、地元福島の復興支援活動や子どもプロジェクトにも積極的に参画しています。2020年は、大空を見上げて笑顔をひろげたいという想いのもと、「Fry for ALL」を実施。日本各地の空にスマイルマークを描き飛行しています。

本リリースの詳細は下記URLをご参照ください。
https://global.toyota/jp/newsroom/lexus/34009653.html

概要:トヨタ自動車株式会社

詳細は http://toyota.jp/ をご覧ください。


Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

エーザイとJD Health、中国における健康サービスプラットフォーム構築に向けた合弁会社を設立

TOKYO, Oct 28, 2020 - (JCN Newswire) - エーザイ株式会社(本社:東京都、代表執行役CEO:内藤晴夫、以下 エーザイ)と京東健康(本社:中国北京市、CEO:辛利軍、以下 JD Health)は、このたび、エーザイの中国子会社である衛材(中国)薬業有限公司(中国江蘇省蘇州市、以下 エーザイ中国)とJD Healthが中国国内における高齢者向けの健康サービスプラットフォーム構築をめざす合弁会社「京颐衛享(上海)健康産業有限公司(Jingyi Weixiang(Shanghai)Health Industry Development Limited Company)」を設立したことをお知らせします。

中国では高齢化が進展しており、2019年末時点での60歳以上の高齢者人口は、総人口の18.1%にあたる2億5388万人に上ります1。急速な高齢化に伴い、高齢者向けの高質な医療・介護に対するニーズが高まっており、その提供が課題となっています。一方、2012年からは民間医療保険下でのオンライン病院が解禁されるなど、デジタル技術を活用した医療分野におけるオンライン化が急速に発展しています2。

エーザイは、アルツハイマー病/認知症領域分野における35年以上の創薬活動の経験と豊富な開発パイプライン、アルツハイマー型認知症治療剤「アリセプト(R)」の販売を通して獲得した認知症当事者やご家族の真のニーズに対する理解に加え、認知症専門医を含む医療関係者とのネットワークを有しています。JD Healthは、強固なeコマースビジネス基盤、インターネット医療サービスのノウハウおよび広大な中国の99%をカバーする物流インフラを有しています。このたび、JD Healthが51%、エーザイ中国が49%を出資して両社の強みを統合した合弁会社を中国に設立し、中国国内に向けた多様な情報・医療サービスから自身に最適なサービスを選択・利用できる高齢者向けの新たなワンストップ健康サービスプラットフォームの構築をめざします。まずは、認知症を対象としたプラットフォームを構築し、将来的に、高齢者に多くみられる幅広い疾患に拡大していく予定です。

本ワンストップ健康サービスプラットフォームは、中国国内において、以下の4つを柱とするサービスを主にオンライン上で提供する予定です。2021年1月以降、許認可の取得など事業準備が整ったサービスより、順次提供を開始する予定です。

- コミュニティサービス:
認知症の疾患啓発・早期発見を目的として、エーザイが有する認知症の疾患啓発に関する情報に加えて、認知機能のセルフチェックや、認知症予防行動の実施・習慣化に向けたツールを、インターネット上のプラットフォームを介して提供します。また、認知症当事者を介護する皆様を対象に、当事者や介護者の皆様同士によるコミュニケーションの場、メンタルヘルスに関する相談窓口およびカウンセリングを受けられる機会を提供し、介護者の皆様が持つ不安、悩みの解消や心のケアに対する支援をめざします。

- 医療サービス:
認知機能に不安を持つ方や認知症当事者に対して、プラットフォームに登録されたインターネット医療サービスを提供する医療機関を紹介し、オンラインによるヘルスケア相談、診察の予約、診察、治療(医薬品の処方からお届けまでを含む)を提供します。認知機能に関する早期の医療相談や診療につなげるとともに、スムーズに診察から治療までのサービスの提供を受けられるよう支援します。

- 介護サービス:
中国の主要な介護施設グループと連携し、対応地域、費用などのリクエストに応じて、認知症当事者とそのご家族が求める最適な介護施設、介護士を紹介します。利用後の評価情報についても蓄積することでさらなる情報の充実につなげます。また、認知症当事者のご家族を含む介護者の皆様に対しては、医療従事者による介護に役立つアドバイス、介護技術習得につながる教育プログラムおよびトレーニングといった幅広いサービスを提供します。プラットフォーム上で介護サービスに関する充実した情報を提供することによって、介護を利用する側と提供する側の双方のニーズを高いレベルで満たしていくことをめざしています。

- モールサービス:
医薬品、ヘルスケア用品、認知症当事者向け生活支援デバイスについて、高齢者ビッグデータから分析された認知症当事者の消費ニーズに基づいてオンライン販売を行います。さらに、認知機能や要介護の程度などの認知症当事者の状態に合わせて、必要とされる可能性の高い製品がオンライン販売画面上にカスタマイズされて提案されます。

エーザイとJD Healthは、両社のナレッジやネットワークを活用し、中国において、高齢者、特に認知症当事者とそのご家族に特化した医療、健康、生活サービスを提供する新たなワンストップ健康サービスプラットフォームを構築することで、中国における医療ニーズの充足に一層貢献してまいります。

本リリースの詳細は下記をご参照ください。
https://www.eisai.co.jp/news/2020/news202068.html

概要:エーザイ株式会社

詳細は www.eisai.co.jp をご覧ください。


Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

三菱自動車、マレーシアで『エクスパンダー』の生産開始

TOKYO, Oct 28, 2020 - (JCN Newswire) - 三菱自動車工業株式会社(本社:東京都港区、代表執行役CEO:加藤 隆雄、以下三菱自動車)はクロスオーバーMPV『エクスパンダー』の現地生産をマレーシアで開始しました。三菱自動車が『エクスパンダー』の生産を行うのは、インドネシア共和国、ベトナム社会主義共和国に次いで3ヶ国目となります。

『エクスパンダー』は、マレーシアにおける車両組立委託先であるHicom Automotive Manufacturers Malaysia Sdn. Bhd.で生産され、同国の総販売代理店Mitsubishi Motors Malaysia Sdn. Bhd.の販売網を通じて今年11月から販売する予定です。

『エクスパンダー』は、近未来的なスタイリングと快適な乗り心地、高い走行性能で好評をいただいており、2017年にインドネシアで販売開始以来、大きな成功を収めており、『エクスパンダー クロス』を含むシリーズ合計で、2020年9月末までの販売台数は約27万台に達しています。

当社CEOの加藤隆雄は生産開始にあたり、「メイドインマレーシアの『エクスパンダー』をマレーシアのお客様にお届けできることを大変嬉しく思います。『エクスパンダー』のマザー工場であるインドネシア工場からは、これまでの完成車輸出に加え、マレーシアでの現地生産に伴う組立部品の輸出が増える計画です。三菱自動車は生産・輸出事業の拡大を通じ、各国の経済の発展に貢献していきます」と述べました。

三菱自動車は本年7月に公表した2022年度までの新中期経営計画「Small but Beautiful」において、アセアンを当社の成長をけん引する重要地域と位置付けています。今回のマレーシアにおける現地生産・販売はパートナーである三菱商事との事業強化の一つであり、今後もアセアンでさらなる成長を目指します。

本リリースの詳細は下記をご参照ください。
https://www.mitsubishi-motors.com/jp/newsrelease/2020/detail5477.html

概要:三菱自動車工業株式会社

三菱自動車の企業コミュニケーションワード「Drive@earth」
地球を走る。地球と生きる。三菱自動車。

人とクルマ、社会とクルマ、地球とクルマの新しい時代を拓くために。いま、三菱自動車は挑戦を始めています。走行中のCO2排出ゼロ。地球温暖化防止に貢献する新世代電気自動車、i MiEV(アイミーブ)の世界投入。軽自動車で培った技術を存分に活用、燃費性能にすぐれたグローバル・スモールの提案。世界の環境基準をクリアしながら、走りの楽しさにあふれた三菱ならではの小型SUVの開発。さらに、新ディーゼルエンジンによるラリー参戦を通じて、走りと環境を両立する、新次元のクルマづくりを追求してゆきます。

私たちは信じています。私たちのクルマへの熱い想いと技術が、新しいクルマの価値をつくることを。ドライブ・アット・アース。走る歓びが永遠であるように。クルマが地球と共生できるように。

詳細はこちらからご覧ください。 www.mitsubishi-motors.co.jp


Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

NECなど、六本木商店街において混雑状況や消費行動などの分析・可視化を行う実証実験を開始

TOKYO, Oct 28, 2020 - (JCN Newswire) - 六本木商店街振興組合(注1)と、日本電気株式会社(注2、以下 NEC)、三井住友カード株式会社(注3、以下 三井住友カード)、および株式会社ナビタイムジャパン(注4、以下 ナビタイム)は、行政や民間が保有する様々なデータの利活用による三密回避・混雑回避に向けた取り組みとして、六本木のまちを対象に、混雑状況や消費行動などの分析・可視化を行う実証実験として、8月から実施した人流情報や購買情報などのデータ収集・分析に基づき、10月28日からスマート街路灯のサイネージに混雑状況の表示を開始します。

本実証は、東京都の「官民連携データプラットフォーム データ利活用実証プロジェクト」における三密回避に向けたプロジェクト「混雑状況と人の流れ・属性、エリア全体の消費動向等の可視化」の一環として実施するものです。

背景

東京都は、本年2月策定の「スマート東京実施戦略」の下、テクノロジーの力で社会課題解決や都民生活の質向上に寄与するサービスが次々生み出されることを目指しており、今年度内には、行政や民間の様々なデータの有効活用を目的としたデータ連携基盤「官民連携データプラットフォーム」の整備を予定しています。

その整備に先立ち、新型コロナウイルス感染症防止対策をはじめとする様々な社会課題の解決に貢献するサービス創出の一環として、今回三密回避をテーマとした本取り組みが選定されました。

本実証の内容

1. 人流情報や購買情報などを組み合わせ、消費と人の動きの相関関係を分析
六本木商店街に設置されたスマート街路灯(注5)に搭載したカメラとAIによる映像解析技術(注6)により、来街者の移動方向、属性(性別・年代)および人数を24時間リアルタイムに推定します。また、三井住友カードのキャッシュレスデータを活用することで、商店街周辺エリアにおける新型コロナウイルス感染拡大前後の消費ボリュームや性別・年代別の消費行動の変化を分析し、ナビタイムの電車混雑情報(注7)と組み合わせ、消費と人の動きへの影響を可視化します。

さらに、これらのデータと東京都が公開しているオープンデータ(新型コロナウイルス感染症情報、犯罪発生情報など)や気象庁の気象データを組み合わせて相関関係を分析し、六本木商店街におけるエリア毎・時間毎などでの傾向を捉えることで、三密回避・混雑回避のための仕組みの調査・検討など、安心して来街者が訪れることができるまちづくりに取り組みます。

2. サイネージなどを活用し、混雑状況を地図でリアルタイムに可視化
六本木商店街に設置されたスマート街路灯に搭載したデジタルサイネージを活用し、収集・分析した混雑状況を地図上にリアルタイムで可視化します。直感的で分かりやすい表示として、東京2020オリンピックスポーツピクトグラムのデザインも手掛けるグラフィックデザイナー廣村正彰(ひろむらまさあき)氏(注8)の監修のもと、ピクトグラム・サイネージコンテンツの手法で可視化しています。これにより、まちの状況を来街者に対してリアルタイムに知らせ、三密を避ける対策につなげることが可能となります。

なお、来街者の推定データ取得に使用する際には、カメラの映像を推定データの生成後に即時破棄します。来街者個人が特定可能な情報は保存せず、統計情報である推定データのみを保存することで、プライバシーに配慮した仕組みを実現しています。カメラ映像の運用については、個人情報保護法をはじめとした関係法令および「カメラ画像利活用ガイドブック」(注9)を遵守の上、関係各機関および有識者からの助言のもと、六本木商店街振興組合としてのガイドラインを独自に作成の上、運営しています。三井住友カードのキャッシュレスデータにおいても、個人および加盟店を特定できないように統計化した情報を使用しております。また、ナビタイムの電車混雑情報は、独自の電車混雑シミュレーション技術で生成した予測データで、個人を特定する情報ではありません。

六本木商店街振興組合・NEC・三井住友カード・ナビタイムは、この実証実験の効果検証を通して、今後も安全・安心で賑わいあるまちづくりを目指す取り組みを進めていきます。

本リリースの詳細は下記をご参照ください。
https://jpn.nec.com/press/202010/20201028_01.html

概要:日本電気株式会社(NEC)

詳細は www.nec.co.jp をご覧ください。


Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

Biotechs get scalable early to late phase clinical offering from Avance Clinical and Cromos Pharma - announced at Bio-Europe 2020

BIO-Europe, Munich, Oct 28, 2020 - (JCN Newswire) - Two dominant regional contract research organizations (CRO), Avance Clinical and Cromos Pharma, with operations in Australia and Central/Eastern Europe, respectively, are successfully collaborating on a scalable clinical solution for biotechs.

The collaboration allows biotechs to quickly start their pre-IND early phase studies in Australia, then expand to Central/Eastern Europe to access the large patient populations for their Phase 2 and 3 studies.

Importantly, the AU/EU model allows biotechs to keep their data and trial management in Australia, and take advantage of the Australian cash rebate of up to 43.5% on clinical trial costs, throughout all study phases, across both regions.

"We are very excited about this model that seamlessly incorporates two of the most compelling and complementary international clinical research hubs for our biotech clients from early to late phase studies," said Yvonne Lungershausen, CEO of Avance Clinical.

"Our eClinical and early phase expertise is well augmented by Cromos Pharma's track record in late stage trials and rapid enrollment capabilities," she continued.

"We have been collaborating with Avance Clinical and referring clients to each other for years," remarked Vlad Bogin, CEO of Cromos Pharma.

"But it was a true Eureka moment when we realized that combining Australia's 43.5% tax rebate with Central/Eastern Europe's unbeatable recruitment rates is a paradigm shift in how clinical trials should be conducted," he concluded.

Cromos Pharma can access hundreds of millions of patients via more than 2,500 sites in Central/Eastern Europe.

About Cromos Pharma, www.cromospharma.com

Cromos Pharma provides tailored and effective clinical trial solutions to support the development of drugs that transform healthcare. An international CRO with over 15 years' experience, we offer fully integrated services performing all aspects of clinical trials in all clinical phases and in a wide range of therapeutic areas. Cromos Pharma delivers rapid recruitment and excellent patient retention as well as expert study design and management. Cromos Pharma has strong regional experience in Central and Eastern Europe with global coverage provided by its US bases in Portland, Oregon and Miami, Florida. Cromos Pharma's European HQ is in Dublin, Ireland. At Cromos Pharma, we know how important your product is. When the stakes are this high, you need a high-performance partner.
Key benefits:
- International expertise combined with in-depth regional knowledge in Central and Eastern Europe (300+ clinical trials conducted in 70+ indications).
- Extensive PI/site and patient network (40,000+ patients enrolled from nearly 2,500 trial sites).
- Unparalleled patient recruitment - our team met or shortened project timelines in 95% of conducted trials.
- Responsible recruitment is supported by Cromos Pharma's "No Patients-No Payments" initiative - a unique risk-sharing program.
- Extremely short startup timelines (e.g. Georgia where we assure a study launch in less than 2 months).
- Expertise in innovative, generics and biosimilar global studies (NDAs, ANDAs, BLAs, 505b2).
- Regulatory inspections and audits that attest to the highest quality of data: EMA in 2019 (1-week oncology site inspection); FDA in 2017 (2-week oncology site inspection).
- Clinical Development Strategy - we provide expert guidance on study design, favorable venues, local and global landscape to improve study outcomes.

About Avance Clinical, www.avancecro.com

Australia's Avance Clinical has more than 20-years of experience and is now one of Australia's leading Contract Research Organizations for biotechs. Avance Clinical is committed to providing high-quality clinical research services with its highly-experienced team.
The collective pool of knowledge and experience at Avance Clinical continually grows through the careful selection of experts who also demonstrate passion in their chosen field.
Avance Clinical offers high-quality services in an established clinical trial ecosystem, that includes world-class Investigators and Sites able to access specialized patient groups.
Other benefits include:
1. The Government R&D grant means up to 43.5% rebate on clinical trial spend
2. eClinical solutions capabilities - speed and continuity
3. Site Initiation Visit (SIV) and Study Start achieved in 5 - 6 weeks
4. No IND required for clinical trials
5. Full GMP material is not mandated for Phase I clinical trials
6. Established clinical trial environment with world-class Investigators and sites
7. Established healthy subject databases and specialized patient populations
8. Five independent Phase 1 facilities across Australia including hospital-based units for critical care
9. Major hospitals with world-class infrastructures and dedicated Clinical Trial Units with a long track-record in FDA compliant research
10. Seasonal studies: Northern hemisphere Sponsors can conduct their studies year-round by taking advantage of Australia's counter-flu and allergy seasons

Media Contacts:
Avance Clinical
Chris Thompson: media@avancecro.com

Cromos Pharma
Nicola Donnelly: media@cromospharma.com


Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

Wintermar Offshore (WINS:JK) Reports 9M2020 Results

JAKARTA, Oct 27, 2020 - (JCN Newswire) - Wintermar Offshore Marine (WINS:JK) has announced results for 9M2020. Wintermar's Owned Vessel revenue for 9M2020 was 17% lower YOY at US$24.6 million and there was a slight improvement on a quarterly basis in 3Q2020 compared to 2Q2020.

--Owned Vessel Division

For the 9M2020 period, Owned Vessel Division recorded a gross loss of US$2.8 million, largely due to cancellations and postponement of contracts caused by the pandemic. Cost efficiency measures and a streamlining of the fleet undertaken since last year led to a 14% YOY decline in Owned Vessel direct expenses, which helped mitigate some of the losses.

On a quarterly basis, revenue for 3Q2020 was slightly improved as compared to 2Q2020 while direct expenses fell.

Measures taken to improve cost efficiency resulted in a 14% reduction in direct expenses for Owned Vessels. Fuel costs dropped sharply by 71% YOY while depreciation fell by 14% YOY due to the sale of 4 vessels in the period 1 January 2020 until 30 September 2020. However, due to the cost of extra precautions taken to ensure the health and safety of crew and clients crewing costs were only 3% lower YOY for 9M2020.

--Chartering and Other Services

Chartering was also negatively affected, contributing US$0.4 million to gross profit as compared to US$1 million in 9M2019. Other Services experienced a similar decline and contributed US$0.3 million to gross profit for 9M2020.

--Indirect Expenses and Operating Loss

Overall, indirect expenses were 15% lower YOY, totaling US$4.5 million for 9M2020. The biggest contributor to these savings was a 15% YOY decline in staff salaries. This was due to lower headcount as well as a voluntary salary reduction supported by all levels of management and staff to mitigate the impact of the pandemic. Marketing and travelling expenses fell YOY by 74% and 43% respectively while lower depreciation also contributed to the cost reduction for 9M2020 compared to 9M2019.

The Operating Loss was 17% YOY higher at US$6.5 million for 9M2020.

--Other Income, Expenses and Net Attributable profit

Interest expenses fell by 27% YOY to US$2.5 million, largely due to lower debt as the Company paid off US$5.7 million of bank loans over the past 9 months. Vessel sale proceeds of US$4,9 million added US$1.2 million to other income, while share of associate companies' losses widened to US$0.4 million from US$0.02 million.

For the nine months ending 30 September 2020, the net loss attributable to shareholders totalled US$7.4 million compared to US$5.7 million in 9M2019.

EBITDA for 9M2020 was US$9 million, compared to US$12.5 million booked in 9M2019.

--Oil & Gas Industry

Activity was slow during 3Q2020, as the world continued to grapple with measures to control the COVID-19 pandemic. In South East Asia, charter rates have been stagnant and are unlikely to drop much further as they are barely covering cash costs. However, leading indicators for oil and gas are turning more positive.

In its October report, the International Energy Agency (IEA) projected that world demand for oil would return to 96.1 million bpd by Q42020 compared to an average of 100.1 million bpd for 2019. This represents a sharp recovery from 2Q2020 where global oil demand fell to the lowest point at 83 million bpd. On the supply side, oil and gas production has been hit hard as many Exploration and Production companies have cut back on investments due to financial pressures. OPEC+ has shown high compliance in maintaining lower production. If IEA projections are achieved, excess oil inventories may be drawn down by end of 2020, which is potentially good news for oil price stability and strength in 2021.

A recent study by Rystad Energy has concluded that deepwater drilling costs have fallen to US$50/barrel, lower than US shale production costs. Should oil prices recover, there are several potential offshore projects in SE Asia which could provide increased gas supply.

SKK MIGAS, Indonesia's regulator for the upstream oil and gas sector, has just reiterated in October 2020 their plans to boost oil and gas production to achieve their target of 1 million bpd by 2030 from 746,000 bpd in 2020. Since Indonesia has several discovered but undeveloped fields, this would actually be an achievable goal if the government is able to deliver on their plans for enhanced oil recovery and exploration.

--Strategy and Outlook

As countries have started to ease their COVID-19 restrictions on travel and business activities, there has been a gradual but steady recovery in oil and gas demand. China, which was early to emerge from lockdown, has shown a sharp recovery in economic growth.

The economic slump and spike in unemployment worldwide is being addressed through stimulus packages proposed by governments around the world. The threat of a resurgence of the virus seems to be handled with more localized lockdown measures to limit the harsh economic effects of COVID-19 "lockdown" restrictions. All this points to a gradual recovery of demand for oil in the coming year.

Although 2020 results will continue to be plagued by the pandemic's effect on reducing oil demand, there has started to be more tendering activity in 4Q2020 which is indicative of better times in 2021.

Rystad Energy research is projecting growth in South East Asian gas production. Wintermar has been building up a presence in Malaysia, Brunei and Myanmar for the past few years, as we position the Company to be a major player in Asia.

Contracts on hand as at end September 2020 amount to US$70 million.
お問合せ先:
Ms. Pek Swan Layanto, CFA Investor Relations PT Wintermar Offshore Marine Tbk Tel: +62-21 530 5201 Ext 401 Email: investor_relations@wintermar.com



Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

エーザイ、第13回アルツハイマー病臨床試験会議(CTAD)においてアルツハイマー病/認知症領域の開発品に関する最新データを発表

TOKYO, Oct 28, 2020 - (JCN Newswire) - エーザイ株式会社(本社:東京都、代表執行役CEO:内藤晴夫)は、2020年11月4日から7日にバーチャルで開催される2020年度のアルツハイマー病臨床試験会議(Clinical Trials on Alzheimer's Disease Conference:CTAD)において、抗アミロイドβ(Aβ)プロトフィブリル抗体lecanemab(開発品コード:BAN2401)の最新データを含む合計7演題を発表することをお知らせします。

Lecanemabについては、4演題の口頭発表を行います。プレクリニカル(無症状期)アルツハイマー病(AD)を対象とする臨床第III相試験として新たに開始した、AHEAD 3-45試験の臨床試験デザインと初期のスクリーニング結果について発表します。また、早期ADを対象として実施した臨床第II相試験(201試験)についてアミロイド関連画像異常(ARIA-E(浮腫))の発現率に関する最新の解析結果、および現在実施中の201試験非盲検継続投与期の最初の12カ月の投与期間における脳内Aβ蓄積量の変化およびARIA-E発現に関する予備的解析結果を発表します。さらに、早期ADを対象として実施中の臨床第III相試験Clarity AD 試験に登録されている当事者様のベースライン時の特徴について発表します。

その他、レンボレキサントにおけるアルツハイマー型認知症に伴う不規則睡眠覚醒リズム障害(ISWRD)を対象とした臨床試験に関連して、マウスモデルにおける本剤の有効性について発表を行います。新規抗MTBR(Microtubule Binding Region:微小管結合領域)タウ抗体E2814による健康成人を対象とした臨床第Ⅰ相単回投与用量漸増試験についても発表します。

また、アデュカヌマブについて、バイオジェン・インク (本社:米国マサチューセッツ州ケンブリッジ、以下バイオジェン)が臨床第IIIb相再投与試験EMBARKの臨床試験デザインについて口頭発表を行います。

当社は、lecanemabおよびアデュカヌマブについて、バイオジェンと共同で開発しています。アデュカヌマブは、2020年8月に米国食品医薬品局(FDA)にAD治療薬としての生物製剤ライセンス申請が受理され、優先審査に指定されています。

シスメックス株式会社(本社:兵庫県、以下 シスメックス)と当社が共同開発している血液を用いた簡便なAD診断法の創出に関して、全自動免疫測定装置HISCL™*で測定した血漿Aβ比によるアミロイドPET検査のセンチロイド法で決定されたアミロイド病理の予測について、ポスター発表があります。

当社は、アルツハイマー病/認知症領域分野における35年以上の創薬活動の経験を基盤に、多元的かつ包括的なアプローチによる創薬研究を通じて、認知症の予防と治癒の実現をめざしています。革新的な治療薬を一日も早く創出し、アンメット・メディカル・ニーズの充足と認知症当事者様とそのご家族のベネフィット向上に、より一層貢献してまいります。

本リリースの詳細は下記をご参照ください。
https://www.eisai.co.jp/news/2020/news202069.html

概要:エーザイ株式会社

詳細は www.eisai.co.jp をご覧ください。


Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

Pacific Green Builds Out Senior Management Team Appointing Xavier Lara As Senior Vice President, Concentrated Solar Power

DOVER, DE, Oct 27, 2020 - (JCN Newswire) - Pacific Green Technologies, Inc. (the "Company" or "PGTK", (OTCQB:PGTK)) announces the appointment of Xavier Lara as Senior Vice President, Concentrated Solar Power, effective October 26, 2020.

Xavier is one of the pre-eminent experts in the Concentrated Solar Power (CSP) sector, with over twenty-five years' experience, including various senior-level roles for AELIUS Engineers and Consultants, Empresarios Agrupados, ACWA Power and NextEra Energy. Xavier joins Pacific Green having recently served as Project Director on billion dollar Cleantech developments around the world.

Scott Poulter, PGTK's Chief Executive commented: "As we continue to build on our existing CSP capabilities, we believe Xavier's unparalleled sales and operations expertise will allow the company to take another step in becoming an industry-leader in this flourishing sector. Xavier brings an exceptional skill set and decades of on-the-ground experience leading flagship CSP projects. Xavier will oversee our rapidly growing CSP business stream and we enthusiastically welcome him to our team."

Xavier Lara, Senior Vice President, Concentrated Solar Power, commented: "Following the acquisition of ENGIN, Pacific Green has positioned itself for success in the CSP space and I look forward to being part of the team to help Pacific Green continue its path to become a world leader in the design and manufacture of CSP systems."

Scott added: "Pacific Green and PowerChina have combined to form an engineering and manufacturing powerhouse, but we believe Xavier's addition to our existing design resources in ENGIN will be instrumental in helping us achieve our goal to be a world leader in this important new sector."

Xavier holds an MEng in Industrial Engineering (Mechanical), an MSc in HSE (Occupational Risk Prevention) and a BSc Hons in Astronomy (Solar Astrophysics).

About Pacific Green Technologies, Inc.

Pacific Green Technologies Inc. is focused on addressing the world's need for cleaner and more sustainable energy. The Company's strategy is to build through organic development and acquisition, a portfolio of patented competitive cutting-edge technologies designed to meet increasingly stringent environmental standards. For more information, visit PGTK's website: www.pacificgreentechnologies.com

About POWERCHINA SPEM Co. Ltd

POWERCHINA SPEM is a subsidiary of POWERCHINA, the largest power equipment manufacturer in the PRC. With abundant resources, expertise, strong manufacturing capacity, domestic sales channels and rich experience, POWERCHINA SPEM is in a strong position to deploy PGTK technology throughout the PRC.

Notice Regarding Forward-Looking Statements:

This news release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this news release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the ongoing effects of the pandemic on delays and orders regarding Pacific Green's technologies, potential business developments around the world and future interest in our green technologies.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, general economic and political conditions, the continuation of the JV with POWERCHINA SPEM, and the ongoing impact of the pandemic. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this news release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Contact:
Scott Poulter, Chairman & CEO
Pacific Green Technologies
T: +1 (302) 601-4659

SOURCE: Pacific Green Technologies, Inc.


Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

Infinito Wallet and Moonstake enable staking and investment tools for Cardano ADA community

SINGAPORE, Oct 27, 2020 - (JCN Newswire) - Infinito Wallet, the leading multi-crypto wallet today announces a multitude of valuable new features targeted at ADA users. These include support for new Cardano blockchain upgrade, staking and trading features for ADA assets, as well as full wallet compatibility with Daedalus and Yoroi Wallet by allowing users to import 24-word and 15-word passphrase, respectively into Infinito Wallet.

This new app release further cements Infinito Wallet's long-standing position to make crypto easy for mass adoption, still with extensive support for the Cardano community.

Starting from September 2018, through a strong collaboration with IOHK, Infinito Wallet has been one of the first mobile wallets supporting ADA. With the recent arrival of Cardano's Shelley era and the explosive growth of ADA's market value by over 50%, Infinito Wallet continues its steady support for ADA user base. Just last month, Infinito Wallet has engaged in a strategic partnership with Moonstake, builder of Asia's Biggest Staking Network to enhance the staking Ecosystem and Defi projects. Starting today, Infinito Wallet users can easily earn staking rewards from ADA Moonstake pool in a few clicks.

Speaking on the recent Cardano-focus development of the wallet, Infinito's Director, Jack Nguyen, says: "Infinito Wallet is honored to continue providing best-in-class support for users invested in ADA and the fast-growing Cardano blockchain. Our wallet has a long and proud history of serving ADA users and now, in collaboration with Moonstake, we are excited to bring them now the ability to earn staking rewards in the new Shelley era of Cardano. Infinito Wallet hopes to continue being the number-one wallet choice for anyone invested in the Cardano ecosystem, and we will always be sure to bring users all the latest and greatest utilities of ADA."

About Infinito

Infinito Wallet is a secure multi-crypto wallet that helps users easily start investing and earning more with the crypto finance market. It supports over 2,000 top-ranking coins and tokens, and provides a full set of financial tools including Buy - Trade - Earn - Use cryptocurrencies. Infinito Wallet is frequently ranked amongst the best wallets for crypto communities. Learn more about Infinito at https://infinitowallet.io.

About Moonstake

Moonstake was recently established to develop a staking pool protocol to satisfy increasing demands in regional and global blockchain markets. Staking adopts Proof of Stake (PoS) as a type of consensus algorithm which allows cryptocurrency holders to increase the likelihood of receiving block rewards from its block validation transaction. It brings together the ability to stake and ultimately distributes block rewards based on contribution. Moonstake develops a staking pool protocol and provides business services through partners and companies. Staking is expected to help elevate the blockchain technology and work for decentralization. https://www.moonstake.io.



Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

CyberVein's CROSS Decentralized NFT Issuance Platform Goes Live

SHANGHAI, Oct 26, 2020 - (JCN Newswire) - CyberVein, the next generation big data and analytics company, announced yet another major technological breakthrough during its Third Anniversary and Re-branding Conference in Shanghai today. The technology company introduced the first-of-a-kind decentralized non-fungible token (NFT) issuance platform, CROSS.

With DAVE (Data Analytics and Valuation Engine), an alliance which enables data-driven and technology companies to utilize their resources more efficiently, the CyberVein team unveiled the CROSS NFT auction functionality during the Renaissance Conference - a celebration of CyberVein's three-year-long journey of technological achievements.

"During the last three years, CyberVein has continued to develop new technologies, built and tested new solutions, and created a whole ecosystem with our partners," stated Jerry Ning, CyberVein's China Operations Director, who's covering the company's activities. He continued: "We are also ever-grateful for our international communities' support, who stood by us since 2017."

CyberVein's Cutting-Edge Technologies

The CROSS platform garners support from the DAVE ecosystem, with more partner companies and foundations set to join the alliance in coming months. CROSS has a unique value proposition in its decentralized NFT issuance and trading capabilities, with a full-category financial derivatives option, which combines Centralized and Decentralized Finance (CeFi+DeFi). CROSS' main objective is to make data more valuable.

DAVE Alliance aims to integrate blockchain companies which work with adjacent technologies, such as big data, Internet-of-Things (IoT), Artificial Intelligence (AI), 5G, and cloud computing, in a bid to create efficiencies. CyberVein will combine the two initiatives by creating a pool of resources with the DAVE engine while underwriting transactions through the CROSS platform's NFT issuance.

"While DAVE combines our existing technologies - directed acyclic graph (DAG), cloud Computing Power GPU, Federated Learning, and PISR Database, we are also keen to collaborate with other technology companies," stated Jack Ge, CyberVein's Global Ambassador. Ge said: "We look forward to achieving even greater things at scale in 2021. Together with our partners, we can make data truly valuable."

About CyberVein
CyberVein was founded in Singapore, CV Technology Foundation, in 2017. It is focusing on the enterprise-level blockchain and big-data customized services. CyberVein is building a new smart city based on ubiquitous connection, digital platform, and omnipresent intelligence to promote the integrated linkage effect of learning, research, finance, industry, and politics. For more information, please visit:

CyberVein: https://www.cybervein.org
Facebook: https://www.facebook.com/cyberveinteam
Twitter: https://twitter.com/cyberveingroup
LinkedIn: https://www.linkedin.com/company/13692190/
Telegram: https://t.me/CyberVeinCommunity
Medium: https://medium.com/cybervein
Reddit: https://www.reddit.com/r/CyberVeinOfficial/
Youtube: https://www.youtube.com/channel/UCpIgOnNTu4FPFsa9LBdQjCw

Media Contact
Rachel, rachelyu@cybervein.org


Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

Taiwan's Sugarcane Straws Explore US Market

TAIPEI, Oct 27, 2020 - (ACN Newswire) - Taiwan not only invented bubble tea that has created a global phenomenon, one of the country's vibrant startup firms has also come up with eco versions of straws that allow you sip through and enjoy chewy tapioca balls, or oversized 'bubbles', in beverages. Among many green solutions providers, Taiwan Plants Fiber Tech Alliance (PFTA) makes plastic-free, bio-degradable straws and cutlery out of sugarcanes and other agricultural waste. It now aims to expand the green product to the US.


PFTA focuses on circular application of agricultural materials and natural plant fiber, such as sugarcane fiber straw, fulfilling the concept of zero waste.


According to the World Bank, the world produced 242 million tons of plastic waste in 2016, 57 million tons originated from Asia Pacific, 45 million tons from Europe and Central Asia, and 35 million tons from North America, and that there will be more plastic in the oceans than fish in 2050 if no action is taken.

In addition, recycling systems around the world are breaking down due to Covid-19 budget strains. Recycling is not enough; a more creative solution is replacing plastic. As Taiwan's bubble tea has taken the world by storm in recent years, its indispensable partner, the straw, is becoming eco-friendly and cool.

PFTA chose sugarcane and plant fibers as raw materials to make one-time or reusable cutlery. Its sugarcane straw is nicknamed 'savior for bubble tea lovers' since Taiwan, home of bubble tea, banned the use of plastic straws at the end of 2019. But long before that, PFTA's sugarcane straw was already welcomed by the Canadian market.

"In 2016, I posted our sugarcane straw on social media to celebrate the success of its commercialization after years of R&D efforts. An interested party from Canada immediately contacted me. He ordered two containers right away," said James Chen, founder and CEO of PFTA. Even if sugarcane straws are twice as expensive as plastic ones, orders from Canada continued to increase. Now this very first customer of PFTA has become its business partner in Canada and has established production lines in Edmonton.

"Sugarcane is grown in abundance in Taiwan. In the Japanese colonial age, sugarcane was a pillar of local economy. Until today, many elderly in Taiwan still share the childhood memories of chewing sugarcanes for fun. Therefore, we manufacture sugarcane straws when there are straws made from cornstarch, paper, bamboo or stainless steel," Chen said.

He said that another reason he chose to use sugarcane is to help reduce agricultural waste. Taiwan is "the kingdom of fruits and vegetables". Abundant agricultural produce means abundant waste. Peels of pineapples, bananas, papayas, or even coffee grounds can be a burden to the environment since they produce methane in the compost or landfills and increase CO2 emission when incinerated.

ASEAN governments also welcome sugarcane straws as bubble tea is getting more popular in their countries. Thailand is the first to adopt PFTA's sugarcane straws. Malaysia banned the use of plastic straws in 2019, Bali and Jakarta of Indonesia banned them in 2020. Striving for a greener future and enforcing its marketing efforts, PFTA approached Green Trade Project Office (GTPO) under Taiwan's Ministry of Economic Affairs for overseas promotional support.

Sugarcane straw is just one of PFTA's many plastic-free products. The company core technology is in its green materials: PFP (Plant Fiber Polymer) No.1 for making reusable products such as plates, bowls, toys, and building materials; and PFP No.2 for single use straws, spoons, and forks.

Chen said that compared with many other countries, the US is a late-comer in adopting green, biodegradable sugarcane straws. This means great market potentials for PFTA. "We are dedicated to establishing a zero-plastic future and circular economy. It's a long, hard journey but we have confidence because we've seen more and more people answering our call."

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

source http://www.acnnewswire.com/press-release/english/62299/

Wintermar Offshore (WINS:JK) Reports 9M2020 Results

JAKARTA, Oct 27, 2020 - (ACN Newswire) - Wintermar Offshore Marine (WINS:JK) has announced results for 9M2020. Wintermar's Owned Vessel revenue for 9M2020 was 17% lower YOY at US$24.6 million and there was a slight improvement on a quarterly basis in 3Q2020 compared to 2Q2020.

--Owned Vessel Division

For the 9M2020 period, Owned Vessel Division recorded a gross loss of US$2.8 million, largely due to cancellations and postponement of contracts caused by the pandemic. Cost efficiency measures and a streamlining of the fleet undertaken since last year led to a 14% YOY decline in Owned Vessel direct expenses, which helped mitigate some of the losses.

On a quarterly basis, revenue for 3Q2020 was slightly improved as compared to 2Q2020 while direct expenses fell.

Measures taken to improve cost efficiency resulted in a 14% reduction in direct expenses for Owned Vessels. Fuel costs dropped sharply by 71% YOY while depreciation fell by 14% YOY due to the sale of 4 vessels in the period 1 January 2020 until 30 September 2020. However, due to the cost of extra precautions taken to ensure the health and safety of crew and clients crewing costs were only 3% lower YOY for 9M2020.

--Chartering and Other Services

Chartering was also negatively affected, contributing US$0.4 million to gross profit as compared to US$1 million in 9M2019. Other Services experienced a similar decline and contributed US$0.3 million to gross profit for 9M2020.

--Indirect Expenses and Operating Loss

Overall, indirect expenses were 15% lower YOY, totaling US$4.5 million for 9M2020. The biggest contributor to these savings was a 15% YOY decline in staff salaries. This was due to lower headcount as well as a voluntary salary reduction supported by all levels of management and staff to mitigate the impact of the pandemic. Marketing and travelling expenses fell YOY by 74% and 43% respectively while lower depreciation also contributed to the cost reduction for 9M2020 compared to 9M2019.

The Operating Loss was 17% YOY higher at US$6.5 million for 9M2020.

--Other Income, Expenses and Net Attributable profit

Interest expenses fell by 27% YOY to US$2.5 million, largely due to lower debt as the Company paid off US$5.7 million of bank loans over the past 9 months. Vessel sale proceeds of US$4,9 million added US$1.2 million to other income, while share of associate companies' losses widened to US$0.4 million from US$0.02 million.

For the nine months ending 30 September 2020, the net loss attributable to shareholders totalled US$7.4 million compared to US$5.7 million in 9M2019.

EBITDA for 9M2020 was US$9 million, compared to US$12.5 million booked in 9M2019.

--Oil & Gas Industry

Activity was slow during 3Q2020, as the world continued to grapple with measures to control the COVID-19 pandemic. In South East Asia, charter rates have been stagnant and are unlikely to drop much further as they are barely covering cash costs. However, leading indicators for oil and gas are turning more positive.

In its October report, the International Energy Agency (IEA) projected that world demand for oil would return to 96.1 million bpd by Q42020 compared to an average of 100.1 million bpd for 2019. This represents a sharp recovery from 2Q2020 where global oil demand fell to the lowest point at 83 million bpd. On the supply side, oil and gas production has been hit hard as many Exploration and Production companies have cut back on investments due to financial pressures. OPEC+ has shown high compliance in maintaining lower production. If IEA projections are achieved, excess oil inventories may be drawn down by end of 2020, which is potentially good news for oil price stability and strength in 2021.

A recent study by Rystad Energy has concluded that deepwater drilling costs have fallen to US$50/barrel, lower than US shale production costs. Should oil prices recover, there are several potential offshore projects in SE Asia which could provide increased gas supply.

SKK MIGAS, Indonesia's regulator for the upstream oil and gas sector, has just reiterated in October 2020 their plans to boost oil and gas production to achieve their target of 1 million bpd by 2030 from 746,000 bpd in 2020. Since Indonesia has several discovered but undeveloped fields, this would actually be an achievable goal if the government is able to deliver on their plans for enhanced oil recovery and exploration.

--Strategy and Outlook

As countries have started to ease their COVID-19 restrictions on travel and business activities, there has been a gradual but steady recovery in oil and gas demand. China, which was early to emerge from lockdown, has shown a sharp recovery in economic growth.

The economic slump and spike in unemployment worldwide is being addressed through stimulus packages proposed by governments around the world. The threat of a resurgence of the virus seems to be handled with more localized lockdown measures to limit the harsh economic effects of COVID-19 "lockdown" restrictions. All this points to a gradual recovery of demand for oil in the coming year.

Although 2020 results will continue to be plagued by the pandemic's effect on reducing oil demand, there has started to be more tendering activity in 4Q2020 which is indicative of better times in 2021.

Rystad Energy research is projecting growth in South East Asian gas production. Wintermar has been building up a presence in Malaysia, Brunei and Myanmar for the past few years, as we position the Company to be a major player in Asia.

Contracts on hand as at end September 2020 amount to US$70 million.

About Wintermar Offshore Marine Group

Wintermar Offshore Marine Group (WINS.JK), developed over nearly 50 years with a track record of quality that is both a source of pride and responsibility that we are dedicated to upholding, and sails a fleet of more than 48 Offshore Support Vessels ready for long term as well as spot charters. All vessels are operated by experienced Indonesian crew, tracked by satellite systems and monitored in real time by shore-based Vessel Teams.

Wintermar is the first shipping company in Indonesia to be certified with an Integrated Management System by Lloyd's Register Quality Assurance, and is currently certified with ISO 9001:2015 (Quality), ISO14001:2015 (Environment) and OHSAS 18001:2007 (Occupational Health and Safety). For more information, please visit www.wintermar.com.
Contact:
Ms. Pek Swan Layanto, CFA Investor Relations PT Wintermar Offshore Marine Tbk Tel: +62-21 530 5201 Ext 401 Email: investor_relations@wintermar.com


Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

source http://www.acnnewswire.com/press-release/english/62298/

Biotechs get scalable early to late phase clinical offering from Avance Clinical and Cromos Pharma - announced at Bio-Europe 2020

BIO-Europe, Munich, Oct 28, 2020 - (ACN Newswire) - Two dominant regional contract research organizations (CRO), Avance Clinical and Cromos Pharma, with operations in Australia and Central/Eastern Europe, respectively, are successfully collaborating on a scalable clinical solution for biotechs.




The collaboration allows biotechs to quickly start their pre-IND early phase studies in Australia, then expand to Central/Eastern Europe to access the large patient populations for their Phase 2 and 3 studies.

Importantly, the AU/EU model allows biotechs to keep their data and trial management in Australia, and take advantage of the Australian cash rebate of up to 43.5% on clinical trial costs, throughout all study phases, across both regions.

"We are very excited about this model that seamlessly incorporates two of the most compelling and complementary international clinical research hubs for our biotech clients from early to late phase studies," said Yvonne Lungershausen, CEO of Avance Clinical.

"Our eClinical and early phase expertise is well augmented by Cromos Pharma's track record in late stage trials and rapid enrollment capabilities," she continued.

"We have been collaborating with Avance Clinical and referring clients to each other for years," remarked Vlad Bogin, CEO of Cromos Pharma.

"But it was a true Eureka moment when we realized that combining Australia's 43.5% tax rebate with Central/Eastern Europe's unbeatable recruitment rates is a paradigm shift in how clinical trials should be conducted," he concluded.

Cromos Pharma can access hundreds of millions of patients via more than 2,500 sites in Central/Eastern Europe.

About Cromos Pharma, www.cromospharma.com

Cromos Pharma provides tailored and effective clinical trial solutions to support the development of drugs that transform healthcare. An international CRO with over 15 years' experience, we offer fully integrated services performing all aspects of clinical trials in all clinical phases and in a wide range of therapeutic areas. Cromos Pharma delivers rapid recruitment and excellent patient retention as well as expert study design and management. Cromos Pharma has strong regional experience in Central and Eastern Europe with global coverage provided by its US bases in Portland, Oregon and Miami, Florida. Cromos Pharma's European HQ is in Dublin, Ireland. At Cromos Pharma, we know how important your product is. When the stakes are this high, you need a high-performance partner.
Key benefits:
- International expertise combined with in-depth regional knowledge in Central and Eastern Europe (300+ clinical trials conducted in 70+ indications).
- Extensive PI/site and patient network (40,000+ patients enrolled from nearly 2,500 trial sites).
- Unparalleled patient recruitment - our team met or shortened project timelines in 95% of conducted trials.
- Responsible recruitment is supported by Cromos Pharma's "No Patients-No Payments" initiative - a unique risk-sharing program.
- Extremely short startup timelines (e.g. Georgia where we assure a study launch in less than 2 months).
- Expertise in innovative, generics and biosimilar global studies (NDAs, ANDAs, BLAs, 505b2).
- Regulatory inspections and audits that attest to the highest quality of data: EMA in 2019 (1-week oncology site inspection); FDA in 2017 (2-week oncology site inspection).
- Clinical Development Strategy - we provide expert guidance on study design, favorable venues, local and global landscape to improve study outcomes.

About Avance Clinical, www.avancecro.com

Australia's Avance Clinical has more than 20-years of experience and is now one of Australia's leading Contract Research Organizations for biotechs. Avance Clinical is committed to providing high-quality clinical research services with its highly-experienced team.
The collective pool of knowledge and experience at Avance Clinical continually grows through the careful selection of experts who also demonstrate passion in their chosen field.
Avance Clinical offers high-quality services in an established clinical trial ecosystem, that includes world-class Investigators and Sites able to access specialized patient groups.
Other benefits include:
1. The Government R&D grant means up to 43.5% rebate on clinical trial spend
2. eClinical solutions capabilities - speed and continuity
3. Site Initiation Visit (SIV) and Study Start achieved in 5 - 6 weeks
4. No IND required for clinical trials
5. Full GMP material is not mandated for Phase I clinical trials
6. Established clinical trial environment with world-class Investigators and sites
7. Established healthy subject databases and specialized patient populations
8. Five independent Phase 1 facilities across Australia including hospital-based units for critical care
9. Major hospitals with world-class infrastructures and dedicated Clinical Trial Units with a long track-record in FDA compliant research
10. Seasonal studies: Northern hemisphere Sponsors can conduct their studies year-round by taking advantage of Australia's counter-flu and allergy seasons

Media Contacts:
Avance Clinical
Chris Thompson: media@avancecro.com

Cromos Pharma
Nicola Donnelly: media@cromospharma.com

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

source http://www.acnnewswire.com/press-release/english/62283/

Endpoints News Presents "Why Australia and Agilex Biolabs for your Next Clinical Trial" for Bio Europe 2020

ADELAIDE, AU, Oct 27, 2020 - (JCN Newswire) - Agilex Biolabs, Australia's most advanced FDA-inspected specialist bioanalytical laboratory for clinical trials, has partnered with Endpoints News to produce an exceptional step-by-step webinar on how to run your trial in Australia, and why Agilex Biolabs is the leading biolabs partner. Watch here (no charge) https://tinyurl.com/yyzf6o44

Agilex Biolabs is known internationally for its continued investment in the latest technology, and for attracting some of the leading scientists from Australia and around the world.

The webinar was launched as part of Agilex Biolabs' presence at Bio Europe. Click here to meet Agilex Biolabs at Bio Europe via the partneringone tool. https://informaconnect.com/bio-europe-virtual/

Dr Kurt J. Sales, Agilex Biolabs Director, Immunoassay B.Sc (Med)(Hons), M.Sc, PhD, PGCM led with a presentation detailing the rapid trials process in Australia.

He stressed the importance of talking to Agilex Biolabs early, even before selecting a CRO and other partners, due to the depth of advice the scientific team can offer Sponsors, and the time it can take to develop some assays.

The webinar also featured leading clinical research specialist Jane Kelly who has 27 years in the industry. She is CEO of CMAX Clinical Research, a major Phase 1 Unit located near Agilex Biolabs.

Kelly pointed to the significant advantages of having the biolabs close to the Phase 1 Unit in terms of sample transfer and data turnaround, and offering a seamless clinical experience for Sponsors.

Agilex Biolabs, the only FDA-inspected lab of its type in the region, also features a rebate of up to 43.5% on clinical trial bioanalytical services spend as part of the Australian Government clinical trial attraction program.

Agilex Biolabs' world-class bioanalytical facilities have OECD GLP Recognition with NATA (Australian Government OECD GLP Compliance monitoring authority) and ISO 17025 Accreditation for global recognition.

The company has recently expanded its labs by more than 30% to accommodate biotech demand from APAC and the USA. Watch the New Labs Walkthrough Video Here https://www.agilexbiolabs.com/new-labs-video

Agilex Biolabs specialises in bioanalysis of small molecules and biologics for PK, immunogenicity, biomarkers and immunological pharmacodynamics assessments utilising LC-MS/MS, immunoassay (Mesoscale, Gurolab, Luminex) and flow cytometry (BD FACSymphony A3, 20 colour cell analyser).

Agilex also offers pharmacodynamics services that include immunobiology services using the latest state-of-the-art technology to support immunology, cell biology and mode of action assays, including:
- Immunophenotyping
- Receptor occupancy
- Cytokine release assays (whole blood or PBMC stimulation assays) and cytokine/biomarker profiling
- PBMC assays and cellular mechanism of action assays (eg: ADCC)

Agilex Biolabs has more than 90 staff including 65 dedicated laboratory staff, and annually support more than 80 clinical trials. This year they will analyse more than 60,000 samples for pharma/biotechs companies from US, Europe and APAC.

Please Book a Briefing with us before you start your next clinical trial. https://calendly.com/agilexbiolabs/15min

Australia: +61 8 8302 8777 | China: +86 21 8036 9483 | South Korea: +82 80 812 1255 | USA: +1 800 247 1909

About Agilex Biolabs https://www.agilexbiolabs.com/

Agilex Biolabs, Australia's leading bioanalytical laboratory, has more than 20 years' experience in performing regulated bioanalysis, including quality method development, method validation and sample analysis services.

Agilex Biolabs has successfully supported hundreds of preclinical and clinical trials around the world where customers choose Australia for the streamlined regulatory process and access to the world's most attractive R&D rebate of more than 40% on clinical trial work conducted in Australia.

The company offers services for both small molecules and biologics for PK, immunogenicity (PD) and biomarker bioanalysis utilising the two platforms of LC-MS/MS and Immunoassay.

Agilex Biolabs operates a fully quality-assured laboratory ensuring that, within the principles of GLP, assays are validated to the latest FDA/EMA guidance and study samples are assayed and reported to the sponsor's desired format using WATSON LIMS. Laboratory certifications include OECD GLP and ISO/IEC17025.

Media Contact:
Media@AgilexBiolabs.com
Kate Newton


Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

Pacific Green Builds Out Senior Management Team Appointing Xavier Lara As Senior Vice President, Concentrated Solar Power

DOVER, DE, Oct 27, 2020 - (ACN Newswire) - Pacific Green Technologies, Inc. (the "Company" or "PGTK", (OTCQB:PGTK)) announces the appointment of Xavier Lara as Senior Vice President, Concentrated Solar Power, effective October 26, 2020.

Xavier is one of the pre-eminent experts in the Concentrated Solar Power (CSP) sector, with over twenty-five years' experience, including various senior-level roles for AELIUS Engineers and Consultants, Empresarios Agrupados, ACWA Power and NextEra Energy. Xavier joins Pacific Green having recently served as Project Director on billion dollar Cleantech developments around the world.

Scott Poulter, PGTK's Chief Executive commented: "As we continue to build on our existing CSP capabilities, we believe Xavier's unparalleled sales and operations expertise will allow the company to take another step in becoming an industry-leader in this flourishing sector. Xavier brings an exceptional skill set and decades of on-the-ground experience leading flagship CSP projects. Xavier will oversee our rapidly growing CSP business stream and we enthusiastically welcome him to our team."

Xavier Lara, Senior Vice President, Concentrated Solar Power, commented: "Following the acquisition of ENGIN, Pacific Green has positioned itself for success in the CSP space and I look forward to being part of the team to help Pacific Green continue its path to become a world leader in the design and manufacture of CSP systems."

Scott added: "Pacific Green and PowerChina have combined to form an engineering and manufacturing powerhouse, but we believe Xavier's addition to our existing design resources in ENGIN will be instrumental in helping us achieve our goal to be a world leader in this important new sector."

Xavier holds an MEng in Industrial Engineering (Mechanical), an MSc in HSE (Occupational Risk Prevention) and a BSc Hons in Astronomy (Solar Astrophysics).

About Pacific Green Technologies, Inc.

Pacific Green Technologies Inc. is focused on addressing the world's need for cleaner and more sustainable energy. The Company's strategy is to build through organic development and acquisition, a portfolio of patented competitive cutting-edge technologies designed to meet increasingly stringent environmental standards. For more information, visit PGTK's website: www.pacificgreentechnologies.com

About POWERCHINA SPEM Co. Ltd

POWERCHINA SPEM is a subsidiary of POWERCHINA, the largest power equipment manufacturer in the PRC. With abundant resources, expertise, strong manufacturing capacity, domestic sales channels and rich experience, POWERCHINA SPEM is in a strong position to deploy PGTK technology throughout the PRC.

Notice Regarding Forward-Looking Statements:

This news release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this news release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the ongoing effects of the pandemic on delays and orders regarding Pacific Green's technologies, potential business developments around the world and future interest in our green technologies.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, general economic and political conditions, the continuation of the JV with POWERCHINA SPEM, and the ongoing impact of the pandemic. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this news release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Contact:
Scott Poulter, Chairman & CEO
Pacific Green Technologies
T: +1 (302) 601-4659

SOURCE: Pacific Green Technologies, Inc.

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

source http://www.acnnewswire.com/press-release/english/62300/

Infinito Wallet and Moonstake enable staking and investment tools for Cardano ADA community

SINGAPORE, Oct 27, 2020 - (ACN Newswire) - Infinito Wallet, the leading multi-crypto wallet today announces a multitude of valuable new features targeted at ADA users. These include support for new Cardano blockchain upgrade, staking and trading features for ADA assets, as well as full wallet compatibility with Daedalus and Yoroi Wallet by allowing users to import 24-word and 15-word passphrase, respectively into Infinito Wallet.




This new app release further cements Infinito Wallet's long-standing position to make crypto easy for mass adoption, still with extensive support for the Cardano community.

Starting from September 2018, through a strong collaboration with IOHK, Infinito Wallet has been one of the first mobile wallets supporting ADA. With the recent arrival of Cardano's Shelley era and the explosive growth of ADA's market value by over 50%, Infinito Wallet continues its steady support for ADA user base. Just last month, Infinito Wallet has engaged in a strategic partnership with Moonstake, builder of Asia's Biggest Staking Network to enhance the staking Ecosystem and Defi projects. Starting today, Infinito Wallet users can easily earn staking rewards from ADA Moonstake pool in a few clicks.

Speaking on the recent Cardano-focus development of the wallet, Infinito's Director, Jack Nguyen, says: "Infinito Wallet is honored to continue providing best-in-class support for users invested in ADA and the fast-growing Cardano blockchain. Our wallet has a long and proud history of serving ADA users and now, in collaboration with Moonstake, we are excited to bring them now the ability to earn staking rewards in the new Shelley era of Cardano. Infinito Wallet hopes to continue being the number-one wallet choice for anyone invested in the Cardano ecosystem, and we will always be sure to bring users all the latest and greatest utilities of ADA."

About Infinito

Infinito Wallet is a secure multi-crypto wallet that helps users easily start investing and earning more with the crypto finance market. It supports over 2,000 top-ranking coins and tokens, and provides a full set of financial tools including Buy - Trade - Earn - Use cryptocurrencies. Infinito Wallet is frequently ranked amongst the best wallets for crypto communities. Learn more about Infinito at https://infinitowallet.io.

About Moonstake

Moonstake was recently established to develop a staking pool protocol to satisfy increasing demands in regional and global blockchain markets. Staking adopts Proof of Stake (PoS) as a type of consensus algorithm which allows cryptocurrency holders to increase the likelihood of receiving block rewards from its block validation transaction. It brings together the ability to stake and ultimately distributes block rewards based on contribution. Moonstake develops a staking pool protocol and provides business services through partners and companies. Staking is expected to help elevate the blockchain technology and work for decentralization. https://www.moonstake.io.


Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

source http://www.acnnewswire.com/press-release/english/62280/

三菱重工、ベンチャーやものづくり企業など様々な仲間が集う共創空間「Yokohama Hardtech Hub」を横浜・本牧に開設

TOKYO, Oct 27, 2020 - (JCN Newswire) - 三菱重工は、ベンチャーやものづくりに携わる企業、自治体、教育機関などが集う共創空間として「Yokohama Hardtech Hub」(以下、「YHH」)を神奈川県横浜市の本牧エリアにオープンしました。社会実装に向けたハードテック(Hardtech)(注1)の革新的なアイデアの創出とその実現の為、共創を通じて新しい技術やビジネスが生まれる場(Hub)となることを目指します。

「YHH」は、当社横浜製作所 本牧工場(横浜市中区)内の建屋を利用し、クレーンや電源等のユーティリティの他、8メートルを超える天井高さ、高い地耐力など、ハードテック企業のモノづくりに対応できる設備を有しています。イベント開催が可能な多目的スペースや会議室などビジネスに必要な設備も兼ね備えた、総床面積約20,000m2の共創空間です。

当社は、「YHH」を技術を核としたイノベーション創発の場として、多種多様なプレーヤーとの繋がりを通じ、ベンチャー企業支援や共創活動、イベント開催などの活動を展開していきます。また、当社グループ社員のアントレプレナーシップや新規事業を育成する場としても活用していきます。さらに、世界各地のイノベーター(革新者)が集まり、新しい産業や文化を生み出していく循環を作り出すことで、横浜市をはじめ地域の活性化にも貢献していきます。

現在、ベンチャー企業をはじめとする志高い仲間の入居を募集するとともに、試作・検証の環境整備のため、熱真空試験装置、温度サイクル試験機、振動試験装置(注2)などの設置を進めています。また、共通課題の解決や共創活動に向けた "YHH共創イベント" を、本年12月より定期的に開催していきます。

詳細は公式ページにて順次掲載
Yokohama Hardtech Hub https://www.mhi.com/jp/company/technology/yhh

安心・安全な社会を目指す共創空間「Yokohama Hardtech Hub」に、どうぞご期待ください。

本リリースの詳細は下記をご参照ください。
https://www.mhi.com/jp/news/201026.html

概要:三菱重工業株式会社

詳細は www.mhi.co.jp をご覧ください。


Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

Global Coalition for Adaptive Research・アムジェン・エーザイ、COVID-19グローバル試験に最初の患者様が登録されたことを発表

TOKYO, Oct 27, 2020 - (JCN Newswire) - Global Coalition for Adaptive Research(米国、カリフォルニア州、ロサンゼルス、以下 GCAR)、アムジェン(米国、カリフォルニア州、サウザンドオークス)、エーザイ株式会社(東京、代表執行役CEO:内藤晴夫、以下 エーザイ)は、このたび、REMAP-CAP (A Randomized, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia)のサブスタディでCOVID-19 による入院患者様に対する複数の治療法を評価する「REMAP-COVID」において、免疫調節療法ドメインに最初の患者様が登録されたことをお知らせします。本ドメインではアムジェンのアプレミラストとエーザイのエリトランが、治療薬候補として評価されます。

REMAP-CAP は、非パンデミックとパンデミックの双方の状況において重症肺炎に対する最適な治療法を見出すように設計されています。この設計に従って、2020 年 2 月、REMAP-CAP はパンデ
ミックモード(REMAP-COVID サブスタディ)に移行し、治験計画に COVID-19 をターゲットとした治験薬投与群を追加し、対象を COVID-19 患者様にも拡大しました。この試験は多施設で行われるランダム化されたプラットフォーム試験であり、作用機序または経路に基づきグループ化された「ドメイン」ごとに、治療剤候補の効果が評価されます。

本治験は、UPMC(University of Pittsburgh Medical Center)ヘルスシステム下にある複数の病院、ならびに米国の 20 を超える病院で実施され、さらにグローバルな治験ネットワークの施設も参加する計画です。また、ピッツバーグ大学は、米国での地域調整センターとして機能します。

REMAP の米国治験責任医師、UPMC ヘルスシステムのチーフヘルスケアイノベーションオフィサーである Derek Angus M.D. MPH、FRCP は「COVID-19 患者様の治療の枠組みを理解するためには、バイオ製薬業界の協力のもと作用機序が良く理解された薬剤を効率的に評価することが重要です。本日の発表は、COVID-19 による入院患者様に対する有望な治療法を評価するための製薬業界とアカデミアのコラボレーションにおいて、重要なマイルストンとなるでしょう」と、述べています。

アムジェンのアプレミラストは、人体の炎症細胞にある PDE4(Phosphodiesterase4)の活性を阻害する経口薬です。アプレミラストは、PDE4 を阻害することにより、炎症性サイトカインやその他のメディエーターの産生を調節すると考えられています。これは、一部の COVID-19 患者様で観察される兆候、症状、肺病変を伴う炎症反応の阻害に役立つ可能性があります。アプレミラストは、中等度から重症の尋常性乾癬、乾癬性関節炎やベーチェット病による口腔潰瘍を含む炎症性疾患の経口治療薬として、現在 45 カ国以上で承認されています。

アムジェンの研究開発担当エグゼクティブ・ヴァイス・プレジデントである David M. Reese M.D.は、「アムジェンは、アプレミラストがその作用機序に基づき、中等度から重度の COVID-19 成人患者様に見られる呼吸困難を防ぐのに役立つ可能性があると考えています。REMAP-COVID は、プラットフォームアプローチを採用した重要かつ革新的な取り組みであり、アプレミラストが中等度から重度の COVID-19 入院患者様の健康状態を改善できるかどうかを迅速に特定できる可能性があり、本プラットフォーム試験に参加できることを誇りに思います」と述べています。

エリトランは、細菌が持つエンドトキシンの活性本体である Lipid A の化学構造アナログで、天然物有機合成技術を駆使した、エーザイ創製の TLR4(Toll-Like Receptor 4)拮抗剤です。重症セプシスの治療薬として開発され、大規模な臨床第Ⅲ相試験を含む 14 の臨床試験でエリトランの安全性が確認されています。サイトカインストームの原因となる多種のサイトカイン産生シグナルの最上流に位置する TLR4 の活性化を阻害することで、COVID-19 による炎症や重症化を抑えることが期待されています。

エーザイ ニューロロジービジネスグループのチーフクリニカルオフィサーであるLynn Kramer, M.D.は、「エーザイは画期的な REMAP-COVID の取り組みに参加できることを嬉しく思います。この研究により、エリトランが中等度から重度の COVID-19 患者様の健康状態を改善する可能性について、重要な知見が得られることを期待しています。当社のヒューマン・ヘルスケア(hhc)理念のもと、COVID-19 と闘う世界中の患者様とそのご家族、医療従事者の皆様に貢献することをめざします」と述べています。

REMAP-COVID のスポンサーである GCAR は、より多くの製薬会社が本試験へ参画するようグローバルに働きかけています。

GCAR の CEO である Meredith Buxton, PhD.は、「GCAR は、私たちが持つ革新的な治験の実行と監督における専門知識を活用することで、この重要な取り組みに協力できることを嬉しく思います。私たちは製薬会社および REMAP ネットワークと緊密に連携し、この重要かつ革新的なプラットフォーム試験のスポンサーとしての役割を果たすことにより、COVID-19 に対する新しい効果的な治療法を特定するよう努めます」と述べています。

本リリースの詳細は下記をご参照ください。
https://www.eisai.co.jp/news/2020/news202067.html

概要:エーザイ株式会社

詳細は www.eisai.co.jp をご覧ください。


Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

昭和電工、会社分割(簡易吸収分割)による光半導体事業の承継に関するお知らせ

TOKYO, Oct 27, 2020 - (JCN Newswire) - 当社は、本日開催の取締役会において、2021 年1月1日を効力発生日として、当社の光半導体事業ならびにレアアース合金事業を、会社分割(吸収分割)により当社の 100%子会社である昭和電工光半導体株式会社(以下、昭和電工光半導体)に承継させること(以下、本会社分割)を決議しましたので、お知らせいたします。

なお、本会社分割は、当社と 100%子会社との間で行う簡易吸収分割となるため、開示事項・内容を一部省略しております。

1.本会社分割の目的

当社は中期経営計画“The TOP 2021”において、収益性と安定性を高レベルで維持する個性派事業の連合体である「個性派企業」の実現を目標に掲げています。当社は中期経営計画において、光半導体事業を「伸ばす」に位置付け、成長が見込まれる市場で、お客様のニーズに応える製品や技術を提供して事業を拡大し、個性派事業に成長することを目指しています。

この事業目標の達成に向け、本事業を事業会社化して意思決定ならびに最新の市場情報に対する社内の情報共有を加速し、成長する赤外領域の受発光デバイスをターゲットに、業界トップの品質とカスタマイズ力によりお客様のご要望にお応えしてまいります。

なお、事業会社化にあたりましては、新たに昭和電工光半導体を設立し、吸収分割により対象事業を同社へ移管いたします。

2.会社分割の要旨

(1)会社分割の日程

吸収分割契約承認 取締役会(当社): 2020 年 10 月 27 日
吸収分割契約 締結日: 2020 年 11 月 6 日
吸収分割契約承認 株主総会(昭和電工光半導体㈱): 2020 年 10 月 27 日
吸収分割契約 効力発生日: 2021 年 1 月 1 日(予定)

(注)本会社分割は、会社法第 784 条第 2 項に基づく簡易分割に該当するため、当社の株主総会の決議を経ずに行う予定です。

(2)会社分割の方式
当社を分割会社とし、昭和電工光半導体を分割承継会社とする吸収分割となります。

(3)会社分割に係る割り当ての内容
昭和電工光半導体は本会社分割に際し、当社に普通株式 100 株を交付します。

(4)会社分割に伴う新株予約権及び新株予約権付き社債に関する取扱い
該当事項はありません。

(5)会社分割により増減する資本金
本会社分割による当社の資本金の増減はありません。

(6)承継会社が承継する権利義務
承継会社である昭和電工光半導体は、当社の光半導体事業ならびにレアアース合金事業に関する権利義務を効力発生日に承継します。

(7)債権履行の見込み
本会社分割後における昭和電工光半導体の債務履行の見込みについては、問題ないと判断しております。

3.会社分割の当事者の概要(2020 年 10 月 27 日現在)

分割会社/承継会社
(1)名称: 昭和電工株式会社/ 昭和電工光半導体株式会社
(2)所在地: 東京都港区芝大門一丁目13番9号/ 埼玉県秩父市下影森1505
(3)代表者の役職・氏名: 代表取締役社長 森川 宏平/ 代表取締役社長 𦥑田 雅彦
(4)事業内容: 石油化学品、ガス製品、特殊化学品、電子・情報関連製品、無機製品、アルミニウム製品等の製造及び販売/ 可視・赤外系 LED、受光用エピウエハー、レアアース合金の製造及び販売
(5)資本金: 140,564 百万円/ 1 円
(6)設立年月日: 1939 年 6 月 1 日/ 2020 年 10 月 9 日
(7)発行済株数: 1,497,112,926 株/ 100 株
(8)決算期: 12 月 31 日/ 12 月 31 日
(9)大株主及び持株比率:
日本マスタートラスト信託銀行株式会社(信託口) 7.24%
KOREA SECURITIES DEPOSITORYSAMSUNG 4.80%
日本トラスティ・サービス信託銀行株式会社(信託口) 3.51%
富国生命保険相互会社 3.09%
日本トラスティ・サービス信託銀行株式会社(信託口7) 2.21%
(10)純資産: 519,433百万円/ 1円
(11)総資産: 1,076,381百万円/ 1円
(12)1株当たり純資産: 3,423円25銭/ 0.01 円
(13)売上高: 906,454百万円/ -
(14)営業利益: 120,798百万円/ -
(15)経常利益: 119,293百万円/ -
(16)親会社株式に帰属する当期純利益: 73,088百万円/ -
(17)1株当たり当期純利益: 501円03銭/ -

(9)について、昭和電工株式会社は 2020 年 6 月 30 日時点のものです。
(10)から(17)については、昭和電工株式会社は 2019 年 12 月期決算のものです。

4.分割する部門の概況

(1)分割する部門の事業内容
当社の可視・赤外系 LED、受光用エピウエハー、レアアース合金の製造及び販売

(2)分割する部門の経営成績(2019 年 12 月期)
売上高: 4,799 百万円

(3)分割する資産、負債の項目および金額

資産
項目: 帳簿価額
流動資産: 1,185 百万円
固定資産: 559 百万円
合計: 1,744 百万円

負債
項目: 帳簿価額
流動負債: 0 百万円
固定負債: 0 百万円
合計: 0 百万円

(注)上記金額は 2020 年 6 月 30 日時点の貸借対照表をもとに算出したものであり、実際に分割する資産・負債の金額は効力発生日までの間に生じた増減を加除した金額となります。

5.分割後の上場会社ならびに吸収分割承継会社の状況

分割会社/承継会社
(1)名称: 昭和電工株式会社/ 昭和電工光半導体株式会社
(2)所在地: 東京都港区芝大門一丁目13番9号/ 埼玉県秩父市下影森1505
(3)代表者の役職・氏名: 代表取締役社長 森川 宏平/ 代表取締役社長 𦥑田 雅彦
(4)事業内容: 石油化学品、ガス製品、特殊化学品、電子・情報関連製品、無機製品、アルミニウム製品等の製造及び販売/可視・赤外系 LED、受光用エピウエハー、レアアース合金の製造及び販売
(5)資本金: 140,564 百万円/ 100 百万円
(6)決算期: 12 月 31 日/ 12 月 31 日

6.今後の見通し

本会社分割は、当社の 100%子会社である連結子会社を承継会社とする会社分割となるため、本会社分割による当社業績への影響は軽微であります。

(ご参考)当期(2020 年 12 月期)連結業績予想(2020 年 8 月 12 日発表)
売上高/ 営業利益/ 経常利益/ 親会社株主に帰属する当期純利益/ 1 株当たり当期純利益
当期連結業績予想: 960,000百万円/△30,000百万円/△55,000百万円/△90,000百万円/△616.94円 銭
2019 年 12 月期連結業績: 906,454百万円/120,798百万円/119,293百万円/73,088百万円/501.03 円 銭

本リリースの詳細は下記URLをご参照ください。
https://www.sdk.co.jp/assets/files/news/2020/20201027_sdknewsrelease_j.pdf

概要:昭和電工株式会社

詳細は www.sdk.co.jp をご覧ください。

お問い合わせ先
CSR・コミュニケーション室
03-5470-3235


Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02